Denali Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $225M | 11M | 20.52 |
| 2023-12-31 | $233M | 11M | 21.46 |
| 2023-09-30 | $219M | 11M | 20.63 |
| 2023-06-30 | $302M | 10M | 29.51 |
| 2023-03-31 | $233M | 10M | 23.04 |
| 2022-12-31 | $277M | 9.9M | 27.81 |
| 2022-06-30 | $244M | 8.3M | 29.43 |
| 2022-03-31 | $261M | 8.1M | 32.17 |
| 2021-09-30 | $412M | 8.2M | 50.45 |
| 2021-06-30 | $600M | 7.6M | 78.44 |
| 2021-03-31 | $466M | 8.2M | 57.10 |
| 2020-12-31 | $664M | 7.9M | 83.76 |
| 2020-09-30 | $240M | 6.7M | 35.83 |
| 2020-06-30 | $171M | 7.1M | 24.18 |
| 2020-03-31 | $121M | 6.9M | 17.51 |
| 2019-12-31 | $108M | 6.2M | 17.42 |
| 2019-09-30 | $94M | 6.1M | 15.34 |
| 2019-03-31 | $153M | 6.6M | 23.22 |
| 2018-12-31 | $135M | 6.6M | 20.62 |
| 2018-09-30 | $105M | 4.8M | 21.74 |
| 2018-06-30 | $48M | 3.2M | 15.25 |
| 2018-03-31 | $22M | 1.1M | 19.70 |
| 2017-12-31 | $15M | 927k | 15.83 |